Advertisement

Topics

WAVE Life Sciences Ltd. Company Profile

10:47 EDT 23rd March 2019 | BioPortfolio

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. Given the versatility of its chemistry platform, WAVE’s pipeline is designed to span multiple oligonucleotide modalities including antisense, exon-skipping, and single-stranded RNAi. For more information, please visit www.wavelifesciences.com and follow us on Twitter and LinkedIn.


News Articles [2183 Associated News Articles listed on BioPortfolio]

Wave Life Sciences plans to design treatments for genetic eye diseases

US-based biotechnology firm Wave Life Sciences has revealed plans to develop new therapeutics for the potential treatment of various rare,...Read More... The post Wave Life Sciences plans to design tr...

Wave Life Sciences Enters FDA's Clinical Trial Pilot Program to Develop DMD Drug

Wave Life Sciences is working to get its nucleic acid treatment, suvodirsen, for Duchenne muscular dystrophy (DMD) approved. DMD is a rare muscle-wasting disease that affects mostly boys, about 15,000...

Wave Life Sciences nets $141mm in FOPO

Wave Life Sciences Ltd. (nucleic acid therapeutic candidates for genetically defined diseases) netted $141mm in a public offering of 3.95mm shares at $38. The company plans to use the proceeds to fund...

Wave Life Sciences to Develop Programs in Rare, Genetic Eye Diseases

Research will focus on inherited retinal diseases associated with RHO, USH2A, ABCA4 and CEP290              Initial development candidate expected in H2 2019 CAMBRIDGE, Mass., Oct. 09, 20...

Wave Life Sciences Prices $150 Million Public Offering of Ordinary Shares

CAMBRIDGE, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a genetic medicines company focused on delivering transformational therapies for patients with serious, ge...

Wave Life Sciences to Present at the Jefferies 2018 London Healthcare Conference

CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, geneti...

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares

CAMBRIDGE, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a genetic medicines company focused on delivering transformational therapies for patients with serious, ge...

Wave Life Sciences to Present at the Cowen 39th Annual Health Care Conference

CAMBRIDGE, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people ba...

Drugs and Medications [69 Associated Drugs and Medications listed on BioPortfolio]

Mondoxyne nl 100mg [oculus innovative sciences]

Monodoxyne NL 100mg

Mondoxyne [oculus innovative sciences]

Mondoxyne NL 50mg

Deltasone [oculus innovative sciences]

Deltasone 20mg prednisone tablets

Complera access [gilead sciences, inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir dis...

Emtriva [gilead sciences, inc.]

These highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule, for oral use EMTRIVA (e...

PubMed Articles [3488 Associated PubMed Articles listed on BioPortfolio]

The protective effect of low-energy shock wave on testicular ischemia-reperfusion injury is mediated by the PI3K/AKT/NRF2 pathway.

Testicular ischemia-reperfusion (IR) injury is the primary pathophysiological consequence of testicular torsion. Low-energy shock wave (LESW) is an effective treatment for certain diseases. The presen...

Systemic and Reflexive: Foundations of Cumulative Dis/Advantage and Life-Course Processes.

Post-Retirement Life Satisfaction and Financial Vulnerability: The Moderating Role of Control.

This paper examines changes in life satisfaction around retirement exits for those with varying pre-retirement incomes, testing whether constraints on control and control over finances moderate the re...

Early-Life Adversity and Dysregulation of Adult Diurnal Cortisol Rhythm.

Exposure to life stresses can lead to diminution in the capacity of stress response systems to mount a robust response to new challenges, with blunting of dynamic range - the spread between maximal at...

SOPHIA ROOSTH, Synthetic: How Life Got Made, Chicago: The University of Chicago Press, 2017, 256 pp, $35.

Clinical Trials [2885 Associated Clinical Trials listed on BioPortfolio]

T-Wave Alternans in Patients With Suspected Acute Coronary Syndrome

The purpose of this study is to measure T-Wave Alternans (TWA) in patients with acute coronary syndrome. Researchers are blinded to clinical TWA measurements. The investigators will then...

Intracardiac T-wave Alternans and Ischemia

T-wave alternans is a test that looks at microvolt changes in the T-wave on a beat to beat basis. The presence or absence of such changes has been shown to predict or exclude future arrhy...

Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy

This trial studies the quality of holographic mm-wave imaging in patients undergoing radiation therapy. Holographic mm-wave imaging is a common type of imaging used in airport body scanner...

T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy

T-wave alternans is an electrocardiographic finding that has been shown to predict the occurrence of future cardiac arrhythmias in patients who have had a heart attack. What is unknown ab...

Hepatitis B and HIV Co-Infection in Patients in Uganda

This study will determine the amount of liver scarring (fibrosis) or liver damage in people infected with 1) hepatitis B virus (HBV, a virus that can infect the liver); 2) HIV (the virus t...

Companies [2105 Associated Companies listed on BioPortfolio]

WaVe Life Sciences

WaVe Life Sciences is leading a revolution in nucleic acid therapeutics and was founded on the core principle that medicines should possess precisely controlled molecular structur...

WAVE Life Sciences Ltd.

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeut...

V-Wave Ltd.

V-Wave is a privately held company with offices in Israel and the U.S. The major investors are Israeli venture firms BRM Group and Pontifax. For further information on V-Wave, vis...

Life Sciences Pennsylvania

Life Sciences Pennsylvania is the statewide trade association for the life sciences in Pennsylvania and serves as a catalyst to ensure Pennsylvania is a global leader in the life ...

Blackstone Life Sciences

Blackstone Life Sciences is a private investment platform with capabilities to invest across the life-cycle of companies and products within the key life science sectors. By combi...

More Information about "WAVE Life Sciences Ltd." on BioPortfolio

We have published hundreds of WAVE Life Sciences Ltd. news stories on BioPortfolio along with dozens of WAVE Life Sciences Ltd. Clinical Trials and PubMed Articles about WAVE Life Sciences Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of WAVE Life Sciences Ltd. Companies in our database. You can also find out about relevant WAVE Life Sciences Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record